Cytokinetics

Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised. They have a robust pipeline of sarcomere-directed therapies with promise for people living with diseases characterized by muscle weakness, loss and dysfunction. Their research is focused on modulating proteins in the sarcomere, the fundamental unit of muscle contraction, found within muscle cells. They are driven to help improve the lives of people with neuromuscular diseases, heart failure and hypertrophic cardiomyopathy.

Cytokinetics is committed to keeping patients at the center of their work and advancing a high integrity, diverse and inclusive culture. They believe that a commitment to a diverse, inclusive, and respectful culture goes beyond what is “right” to do; it is foundational to building a successful, creative, and science driven company. They offer a comprehensive benefits package for their employees including health, financial, time off, onsite services, and more. Cytokinetics is also committed to community engagement, supporting a more sustainable world and patient advocacy.

Cytokinetics provides employees with a comprehensive benefits package designed to support their health and financial well-being. These benefits include comprehensive health insurance plans, financial planning resources, generous time off options, and convenient onsite services, among others.

Cytokinetics is a late-stage biopharmaceutical company committed to developing novel medicines that improve muscle function in individuals suffering from debilitating diseases like heart failure, hypertrophic cardiomyopathy (HCM Disease), and neuromuscular diseases. Their mission centers on empowering muscle and, in turn, empowering lives through research, development, and commercialization of potential medicines that may preserve and extend independence for those affected by these conditions.

Cytokinetics fosters a culture that values collaboration, integrity, and innovation. They prioritize patient-centricity, striving to understand and address patients' needs in every aspect of their work. This is reflected in their emphasis on transparency, diversity, inclusion, and respect. They encourage employees to be their authentic selves, embrace challenges, and work together to achieve their mission of improving the lives of patients with compromised muscle function.

Cytokinetics is committed to fostering a diverse, equitable, and inclusive workplace where everyone feels valued, respected, and encouraged to be their authentic selves. They believe that a diverse workforce, with varying ideas, cultures, and backgrounds, drives innovation and ingenuity. Their commitment goes beyond words, with structured programs including a DEIR council and working groups, company-wide educational sessions and training, employee resource groups, events celebrating cultural and heritage observances, and opportunities for employees to share personal stories and perspectives.